Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher S Hourigan

Showing results (51-60 of 145) with videos related to

Pageof 15
Sort By:
Clinical Hematology International|September 14, 2020
B cell deficiency in patients with relapsed and refractory acute myeloid leukemiaMeghali Goswami, Katherine E Lindblad, Rahul Ramraj, et al.
Frontiers in Immunology|May 14, 2023
Prediction of HLA genotypes from single-cell transcriptome dataBenjamin D Solomon, Hong Zheng, Laura W Dillon, et al.
Cytometry. Part B, Clinical Cytometry|April 26, 2024
Flow cytometric immunophenotypic differentiation patterns of bone marrow eosinophilopoiesisChristopher J Trindade, Xiaoping Sun, Dragan Maric, et al.
Blood|February 17, 2020
Baseline TP53 mutations in adults with SCD developing myeloid malignancy following hematopoietic cell transplantationJack Y Ghannam, Xin Xu, Irina Maric, et al.
Genes & Development|March 8, 2019
The splicing factor U2AF1 contributes to cancer progression through a noncanonical role in translation regulationMurali Palangat, Dimitrios G Anastasakis, Dennis Liang Fei, et al.
Blood|August 31, 2022
Increased incidence of hematologic malignancies in SCD after HCT in adults with graft failure and mixed chimerismRialnat A Lawal, Devdeep Mukherjee, Emily M Limerick, et al.
Journal of Palliative Medicine|May 25, 2017
A Single Center Survey of Health-Related Quality of Life among Acute Myeloid Leukemia Survivors in First Complete RemissionM Jennifer Cheng, B Douglas Smith, Christopher S Hourigan, et al.
Bone Marrow Transplantation|January 5, 2024
Persistent IDH mutations are not associated with increased relapse or death in patients with IDH-mutated acute myeloid leukemia undergoing allogeneic hematopoietic cell transplant with post-transplant cyclophosphamideNiveditha Ravindra, Laura W Dillon, Gege Gui, et al.
Medrxiv : the Preprint Server for Health Sciences|September 4, 2023
Persistent <i>IDH</i> mutations are not associated with increased relapse or death in patients with <i>IDH</i>-mutated acute myeloid leukemia undergoing allogeneic hematopoietic cell transplant with post-transplant cyclophosphamideNiveditha Ravindra, Laura W Dillon, Gege Gui, et al.
JCI Insight|December 7, 2018
Human bone marrow assessment by single-cell RNA sequencing, mass cytometry, and flow cytometryKarolyn A Oetjen, Katherine E Lindblad, Meghali Goswami, et al.
Pageof 15

Showing results (51-60 of 145) with videos related to

Sort By:
Pageof 15
Clinical Hematology International|September 14, 2020
B cell deficiency in patients with relapsed and refractory acute myeloid leukemiaMeghali Goswami, Katherine E Lindblad, Rahul Ramraj, et al.
Frontiers in Immunology|May 14, 2023
Prediction of HLA genotypes from single-cell transcriptome dataBenjamin D Solomon, Hong Zheng, Laura W Dillon, et al.
Cytometry. Part B, Clinical Cytometry|April 26, 2024
Flow cytometric immunophenotypic differentiation patterns of bone marrow eosinophilopoiesisChristopher J Trindade, Xiaoping Sun, Dragan Maric, et al.
Blood|February 17, 2020
Baseline TP53 mutations in adults with SCD developing myeloid malignancy following hematopoietic cell transplantationJack Y Ghannam, Xin Xu, Irina Maric, et al.
Genes & Development|March 8, 2019
The splicing factor U2AF1 contributes to cancer progression through a noncanonical role in translation regulationMurali Palangat, Dimitrios G Anastasakis, Dennis Liang Fei, et al.
Blood|August 31, 2022
Increased incidence of hematologic malignancies in SCD after HCT in adults with graft failure and mixed chimerismRialnat A Lawal, Devdeep Mukherjee, Emily M Limerick, et al.
Journal of Palliative Medicine|May 25, 2017
A Single Center Survey of Health-Related Quality of Life among Acute Myeloid Leukemia Survivors in First Complete RemissionM Jennifer Cheng, B Douglas Smith, Christopher S Hourigan, et al.
Bone Marrow Transplantation|January 5, 2024
Persistent IDH mutations are not associated with increased relapse or death in patients with IDH-mutated acute myeloid leukemia undergoing allogeneic hematopoietic cell transplant with post-transplant cyclophosphamideNiveditha Ravindra, Laura W Dillon, Gege Gui, et al.
Medrxiv : the Preprint Server for Health Sciences|September 4, 2023
Persistent <i>IDH</i> mutations are not associated with increased relapse or death in patients with <i>IDH</i>-mutated acute myeloid leukemia undergoing allogeneic hematopoietic cell transplant with post-transplant cyclophosphamideNiveditha Ravindra, Laura W Dillon, Gege Gui, et al.
JCI Insight|December 7, 2018
Human bone marrow assessment by single-cell RNA sequencing, mass cytometry, and flow cytometryKarolyn A Oetjen, Katherine E Lindblad, Meghali Goswami, et al.
Pageof 15